Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/45003 
Autor:innen: 
Erscheinungsjahr: 
2010
Schriftenreihe/Nr.: 
Duisburg Working Papers on East Asian Studies No. 87/2010
Verlag: 
University of Duisburg-Essen, Institute of East Asian Studies (IN-EAST), Duisburg
Zusammenfassung: 
Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development.
Schlagwörter: 
China
health biotechnology
innovation system
pharmaceutical
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
1.37 MB





Publikationen in EconStor sind urheberrechtlich geschützt.